Show simple item record

dc.contributor.authorDhar, Shanta
dc.contributor.authorDaniel, Weston L.
dc.contributor.authorGiljohann, David A.
dc.contributor.authorMirkin, Chad A.
dc.contributor.authorLippard, Stephen J.
dc.date.accessioned2013-11-18T13:18:42Z
dc.date.available2013-11-18T13:18:42Z
dc.date.issued2009-09
dc.date.submitted2009-08
dc.identifier.issn0002-7863
dc.identifier.issn1520-5126
dc.identifier.urihttp://hdl.handle.net/1721.1/82149
dc.description.abstractAmine-functionalized polyvalent oligonucleotide gold nanoparticles (DNA-Au NPs) were derivatized with a cisplatin prodrug, and the resulting DNA-Au NP conjugates were used to internalize multiple platinum centers. A platinum(IV) complex, c,c,t-[Pt(NH[subscript 3])[subscript 2]Cl[subscript 2](OH)(O[subscript 2]CCH[subscript 2]CH[subscript 2]CO[subscript 2]H)], was tethered to the surface of DNA-Au NPs through amide linkages. The platinum-tethered gold nanoparticles were taken into several cancer cells. The drop in intracellular pH facilitated reductive release of cisplatin from the prodrug, which then formed 1,2-d(GpG) intrastrand cross-links in the cell nuclei, as confirmed by an antibody specific for this adduct. The cytotoxicity of the platinum(IV) complex increases significantly in several cancer cell lines when the complex is attached to the surface of the DNA-Au NPs and in some instances exceeds that of cisplatin.en_US
dc.description.sponsorshipNational Cancer Institute (U.S.) (Grant CA034992)en_US
dc.description.sponsorshipNational Cancer Institute (U.S.) (MIT-Harvard Center for Cancer Nanotechnology Excellence 5U54CA11934)en_US
dc.description.sponsorshipDavid H. Koch Institute for Integrative Cancer Research at MITen_US
dc.language.isoen_US
dc.publisherAmerican Chemical Society (ACS)en_US
dc.relation.isversionofhttp://dx.doi.org/10.1021/ja9071282en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourcePMCen_US
dc.titlePolyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) Warheadsen_US
dc.typeArticleen_US
dc.identifier.citationDhar, Shanta, Weston L. Daniel, David A. Giljohann, Chad A. Mirkin, and Stephen J. Lippard. “Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) Warheads.” Journal of the American Chemical Society 131, no. 41 (October 21, 2009): 14652-14653.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemistryen_US
dc.contributor.mitauthorDhar, Shantaen_US
dc.contributor.mitauthorDaniel, Weston L.en_US
dc.contributor.mitauthorLippard, Stephen J.en_US
dc.relation.journalJournal of the American Chemical Societyen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsDhar, Shanta; Daniel, Weston L.; Giljohann, David A.; Mirkin, Chad A.; Lippard, Stephen J.en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-2693-4982
mit.licensePUBLISHER_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record